Discovery Life Sciences Appoints Chief Scientific Officer to Drive Company's Rapid Global Expansion of Biomarker Services

Read More

Discovery Life Sciences Installs the Largest Olink Platform in the Americas to Support Proteomics Research & Biomarker Development at Scale

Read More

Discovery Life Sciences Appoints Executive Vice President to Support Rapid Progress in Proteomics

Read More

Discovery Life Sciences Acquires AllCells

Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells®  , a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products.  With more than ...
Read More

Discovery Life Sciences’ HudsonAlpha Discovery Becomes One of the World’s Largest PacBio HiFi Sequencing Service Providers

ESTABLISHES A SINGULAR, LARGE-SCALE HIFI LONG READ SEQUENCING SERVICE FOR THE BIOPHARMACEUTICAL INDUSTRY
Read More

Discovery Life Sciences To Acquire Gentest Business From Corning Incorporated

Biospecimen Leader to Combine Gentest with Recent IVAL Acquisition to Create Leading In Vitro Drug Metabolism Services Offering
Read More
Discovery Life Sciences Streamlines Cell And Gene Therapy Manufacturing With Expanded Human Cellular Starting Materials

Discovery Life Sciences Streamlines Cell And Gene Therapy Manufacturing With Expanded Human Cellular Starting Materials

Read More

Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies

Delivery of 100,000 Samples of Capacity Annually to the Market, Empowering Genomics Researchers to Add Deep, Unbiased Proteomics Analysis to their Studies
Read More

Discovery Life Sciences Acquires In Vitro ADMET Laboratories

Biospecimen Leader Gains World’s Largest Hepatocyte Inventory And World-Renowned Scientific Leader With Latest Acquisition
Read More

Discovery Life Sciences Launches TruSight Oncology 500 (TSO500) Solid Tumor FFPE and cfDNA Services to Advance Liquid Biopsy Development and Immunotherapy Clinical Research

HUNTSVILLE, Ala., Nov. 12, 2020, Discovery Life Sciences™ (Discovery), a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, announces the addition of Illumina’s TruSight Oncology 500 (TSO500) technology ...
Read More

To propel your projects with The Power of Discovery.™

Contact Us Today

Let us know about your project!

Image